Individualizing Therapy in Low-Risk MDS: New Evidence and Options for Your Patients

Gain expert insights on the latest advancements in managing low-risk myelodysplastic syndromes through an on-demand webcast of a roundtable discussion and a commentary addressing audience questions from a live webinar.

Share

Program Content

Activities

Managing LR MDS
Individualizing Therapy in Low-Risk MDS: New Evidence and Options for Your Patients
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 31, 2024

Expires: May 30, 2025

Activities

Myelodysplastic Syndromes at ASCO 2024
Individualizing Therapy in Low-Risk MDS: New Evidence and Options for Your Patients
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 14, 2024

Expires: December 13, 2024

Activities

FAQs on LR-MDS
Experts Answer Key Questions on Managing Anemia in Patients With Lower-Risk MDS
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 08, 2024

Expires: July 07, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb